To Assess the Safety of Ciclesonide, Applied as a Nasal Spray at Three Dose Levels, in the Treatment of Perennial Allergic Rhinitis in Pediatrics (BY9010/M1-405)

PHASE3CompletedINTERVENTIONAL

Enrollment

120

Participants

Timeline

Start Date

September 30, 2004

Primary Completion Date

April 30, 2005

Study Completion Date

November 30, 2005

Conditions

Rhinitis, Allergic, PerennialHay Fever

Interventions

DRUG

Ciclesonide nasal

safety of Ciclesonide (200µg, 100µg, 25µg)

DRUG

Placebo

placebo

Trial Locations (1)

Altana/Nycomed, Little Rock